ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related Diseases
Open accessThe DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Abstract
The aging process worsens the human body functions at multiple levels, thus causing its gradual decrease to resist stress, damage, and disease. Besides changes in gene expression and metabolic control, the aging rate has been associated with the production of high levels of Reactive Oxygen Species (ROS) and/or Reactive Nitrosative Species (RNS). Specific increases of ROS level have been demonstrated as potentially critical for induction and maintenance of cell senescence process. Causal connection between ROS, aging, age‐related pathologies, and cell senescence is studied intensely. Senescent cells have been proposed as a target for interventions to delay the aging and its related diseases or to improve the diseases treatment. Therapeutic interventions towards senescent cells might allow restoring the health and curing the diseases that share basal processes, rather than curing each disease in separate and symptomatic way. Here, we review observations on ROS ability of inducing cell senescence through novel mechanisms that underpin aging processes. Particular emphasis is addressed to the novel mechanisms of ROS involvement in epigenetic regulation of cell senescence and aging, with the aim to individuate specific pathways, which might promote healthy lifespan and improve aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ability of GHK and its Cu chelate to promote skin remodeling, wound healing and regeneration, and its prominent antioxidant and anti-inflammatory effects are qualities that will help enhance healthy aging [28–31].”
From The potential of GHK as an anti-aging peptide (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, ROS induces cell death11, cell senescence, repair failure12, inhibition of cell proliferation, and cell cycle arrest13.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 1×
“Among short ncRNAs, the microRNAs (miRNAs) have emerged as being able to control the gene expression, either by blocking targeted mRNA translation or by mRNA degrading [220, 221].”
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 2×
““Redox biology,” rather than OS, has been proposed to underlie both physiological and pathological events [37].”
BackgroundOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Also, a delicate balance exists between cell senescence positive effects on tumor suppression and negative effects on aging related processes [164].”
BackgroundLandscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187 · cited 1×
“Latest genomics tools and sequencing approaches have helped unravel large chromosomes stretches, which were previously deemed not transcribed [218, 219].”
BackgroundReactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Ray, P. D., Huang, B.-W., & Tsuji, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.008 · Cited by 4,373 · cited 4×
“PPARγ (i) Redox sensor function [43] (ii) Regulation of genes that modulate ROS increases [44] Neurodegenerative diseases [65, 66] Lipid dysfunction (fatty liver) [59]”
BackgroundInfluentialRole of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775 · cited 1×
“The Polycomb Repressor Complex 2 (PRC2) initiates and preserves specific histone methylations, thus acting as an epigenetic mark that mediates targeted genes [207].”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“While the sequence of proliferative arrest (senescence), recruitment of immune phagocytic cells (clearance), and promotion of tissue renewal (regeneration) results in being beneficial upon a damaged tissue, for instance, the sequence is inefficiently completed in aging tissues, causing senescent cells to undergo chron…”
BackgroundCrosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505 · cited 2×
“Receptor-dependent or nondependent tyrosine kinases, AMP-activated protein kinases, adaptor protein p66SHC, and transcription factors as FOXO (forkhead homeobox type O), Nrf2 (nuclear factor E2-related factor 2), p53 (tumor suppressor 53), NFκB (nuclear factor kappa B), AP-1 (activator protein-1), HIF-1a (hypoxia indu…”
BackgroundFree Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
Phaniendra, A., Jestadi, D. B., & Periyasamy, L. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0446-0 · Cited by 2,886 · cited 2×
“ROS are recognized as key modulators in processes that accumulate oxidized molecules chronically, as diabetes, cardiovascular diseases, atherosclerosis, hypertension, ischemia, reperfusion injury, neurodegeneration, and rheumatoid arthritis [17].”
BackgroundCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 2×
“When the senescent cell program is inefficiently developed, as it occurs during the aging, the secretoma causes detrimental effects [151–153, 167, 168, 199].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 7×
“Some observations indicate that senescent cells do not necessarily induce mechanisms that promote aging and can be efficiently removed from the human body [9].”
BackgroundInfluentialThe role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381 · cited 1×
“ROS is integral in the development of physiopathologic events like mitochondrial death signaling [86] and autophagy [87], besides inflammation and infection [55, 88], in which they impart immunological changes.”
BackgroundOxidative stress and autophagy: The clash between damage and metabolic needs
Filomeni, G., De Zio, D., & Cecconi, F. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.150 · Cited by 2,195 · cited 1×
“ROS is integral in the development of physiopathologic events like mitochondrial death signaling [86] and autophagy [87], besides inflammation and infection [55, 88], in which they impart immunological changes.”
BackgroundThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 1×
“Senescent cells proliferate in aging, as a stress response primed by a number of “countingmechanisms,” like telomeres shortening, DNA damage accumulation, abnormal oncogenes activities, metabolic alterations, and excessive ROS generation [7].”
BackgroundLong noncoding RNAs: past, present, and future
Kung, J. T. Y., Colognori, D., & Lee, J. T. (2013) · Genetics · doi:10.1534/genetics.112.146704 · Cited by 1,874 · cited 1×
“Latest genomics tools and sequencing approaches have helped unravel large chromosomes stretches, which were previously deemed not transcribed [218, 219].”
BackgroundOxidative Stress, Prooxidants, and Antioxidants: The Interplay
Rahal, A., Kumar, A., Singh, V., Yadav, B., Tiwari, R., Chakraborty, S., & Dhama, K. (2014) · BioMed Research International · doi:10.1155/2014/761264 · Cited by 1,706 · cited 1×
“Increased expression of catalase and peroxiredoxin 1 molecules are considered as OS markers [20–22].”
BackgroundJmjC-domain-containing proteins and histone demethylation
Klose, R. J., Kallin, E. M., & Zhang, Y. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1945 · Cited by 1,290
Promoting Health and Longevity through Diet: From Model Organisms to Humans
Fontana, L., & Partridge, L. (2015) · Cell · doi:10.1016/j.cell.2015.02.020 · Cited by 1,245 · cited 1×
“In parallel, all the suggested methods to prolong lifespan, as caloric restriction and increased activity of SIRT1, share the OS reduction effect [107].”
BackgroundThiol chemistry and specificity in redox signaling
Winterbourn, C. C., & Hampton, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.004 · Cited by 1,226 · cited 1×
“This molecule functions as OS/NS sensor within enzymes and transcriptional regulatory factors and may allow priming the routes of the versatile ROS action [34–36].”
BackgroundLaberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 1×
“However, the secretoma may provide indispensable cytokines for the cancer cells growth, thus promoting tumorigenesis in definite conditions, which are partly related to the cellular metabolic state [155].”
BackgroundSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“In conclusion, cell senescence reduces the age-related tumor development and contributes to human aging, suggesting that aging might be switched for tumorigenesis [201, 202].”
BackgroundThe role of mitochondria in aging
Bratic, A., & Larsson, N.-G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64125 · Cited by 1,087 · cited 1×
“For example, mitochondria-nucleus interplay [101] and alterations of mitochondrial homeostasis drive age-dependent modifications [102, 103].”
BackgroundOxidative Stress in Aging Human Skin
Rinnerthaler, M., Bischof, J., Streubel, M., Trost, A., & Richter, K. (2015) · Biomolecules · doi:10.3390/biom5020545 · Cited by 1,053 · cited 1×
“The variations of speed and quality in the aging of each organism may reflect the peculiar alterations that have been accumulated in DNA, proteins, and lipids [120], following the organism exposition to chronic stressors.”
BackgroundFreund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039
Feedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019
Oxidative Stress and Oxidative Damage in Carcinogenesis
Klaunig, J. E., Kamendulis, L. M., & Hocevar, B. A. (2010) · Toxicologic Pathology · doi:10.1177/0192623309356453 · Cited by 957 · cited 1×
“HIF-1a Cell adaption to oxygen tension modifications [52] Cell proliferation; angiogenesis [77] Cell transformation [78, 79]”
Wang (2012) · doi:10.1161/circresaha.111.261388 · Cited by 957 · cited 2×
“Aged vascular tissues Telomeres length, SA-βGal, p16, and p21 [170, 171]”
BackgroundRedox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
Free radicals and antioxidants: updating a personal view
Halliwell, B. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00476.x · Cited by 912 · cited 1×
“Signaling pathways via Ras, p53, p21, and p16 have been defined to generate ROS, which may act as tightly regulated process contributing to the cell senescence induction [20, 157, 158].”
BackgroundIdentification of Renox, an NAD(P)H oxidase in kidney
Geiszt, M., Kopp, J. B., Várnai, P., & Leto, T. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130135897 · Cited by 842 · cited 1×
“ROS act like a sensor in regulating the oxygen-dependent gene expression of the kidney and play a leading role in the inflammatory processes, to which the organ is especially sensitive [162].”
BackgroundTebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
ROS and p53: A versatile partnership
Liu, B., Chen, Y., & St. Clair, D. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.011 · Cited by 830 · cited 2×
“Receptor-dependent or nondependent tyrosine kinases, AMP-activated protein kinases, adaptor protein p66SHC, and transcription factors as FOXO (forkhead homeobox type O), Nrf2 (nuclear factor E2-related factor 2), p53 (tumor suppressor 53), NFκB (nuclear factor kappa B), AP-1 (activator protein-1), HIF-1a (hypoxia indu…”
BackgroundDNA Methylation: Superior or Subordinate in the Epigenetic Hierarchy?
Jin, B., Li, Y., & Robertson, K. D. (2011) · Genes & Cancer · doi:10.1177/1947601910393957 · Cited by 817 · cited 2×
“The interplay between modified histones, DNAmethylation, regulator noncoding RNAs, and other reversible processes constitutes the epigenetic machinery that regulates genes transcription and expression [123].”
BackgroundSenescence and aging: the critical roles of p53
Rufini, A., Tucci, P., Celardo, I., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2012.640 · Cited by 798 · cited 2×
“Particular emphasis is addressed to novel mechanism of ROS and epigenetics in cell senescence and aging [160, 165, 166].”
BackgroundTripathi, V., Shen, Z., Chakraborty, A., Giri, S., Freier, S. M., Wu, X., Zhang, Y., Gorospe, M., Prasanth, S. G., Lal, A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003368 · Cited by 754 · cited 1×
“The senescence-associated lncRNAs are differentially expressed in proliferating and senescent fibroblasts, as assessed by RNA sequencing [224–226].”
BackgroundThe signaling mechanism of ROS in tumor progression
Wu, W.-S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9037-8 · Cited by 752
Redox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747 · cited 1×
“FOXO3A Cell coordination in response to OS [51] Metabolic adaptation to low nutrient intake [73] Cancer development [73] Diabetes [74] Atherosclerotic cardiovascular disease [75]”
BackgroundExtending life span by increasing oxidative stress
Ristow, M., & Schmeisser, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.010 · Cited by 722 · cited 2×
“Mitochondrial ROS may activate an adaptive response (mitohormesis), which, as defensive mechanism, promotes health to extend the lifespan through diseases prevention and delay [5, 85].”
BackgroundErasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
Cloos, P. A. C., Christensen, J., Agger, K., & Helin, K. (2008) · Genes & Development · doi:10.1101/gad.1652908 · Cited by 669 · cited 1×
“which erases the methyl mark [208].”
Role of peroxisomes in ros/rns-metabolism: Implications for human disease
Fransen, M., Nordgren, M., Wang, B., & Apanasets, O. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.001 · Cited by 644 · cited 1×
“The family comprises seven transmembrane members, namely, Nox1– 5 [13–15] and Duox1-2 [16].”
BackgroundNrf2 regulates ROS production by mitochondria and NADPH oxidase
Kovac, S., Angelova, P. R., Holmström, K. M., Zhang, Y., Dinkova-Kostova, A. T., & Abramov, A. Y. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.021 · Cited by 604 · cited 1×
“Nrf2 Cell adaptation to ROS resistance [49, 50] Apoptosis [70] Neurodegenerative diseases [71] Cardiovascular diseases [72]”
BackgroundMetabolic Syndrome, Aging and Involvement of Oxidative Stress
Bonomini, F., Rodella, L. F., & Rezzani, R. (2015) · Aging and Disease · doi:10.14336/ad.2014.0305 · Cited by 599 · cited 2×
“Poor knowledge of basic processes in aging interferes with interventions to prevent or delay age-related pathologies, like diabetes, cardiovascular disorders, neurodegenerative disorders, and cancer, which, consequently, impact human independence, general wellbeing, and morbidity [97–99].”
BackgroundSites of reactive oxygen species generation by mitochondria oxidizing different substrates
Quinlan, C. L., Perevoshchikova, I. V., Hey-Mogensen, M., Orr, A. L., & Brand, M. D. (2013) · Redox Biology · doi:10.1016/j.redox.2013.04.005 · Cited by 595 · cited 1×
“The inefficient electron transfer in mitochondrial respiratory chain is believed to be a main ROS source, among diverse possible enzymatic and nonenzymatic sources [12].”
BackgroundAstrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586 · cited 2×
“Alzheimer’s disease SA-β-gal [189, 190]”
BackgroundReactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis
Ziech, D., Franco, R., Pappa, A., & Panayiotidis, M. I. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.02.015 · Cited by 568
JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells
Pasini, D., Cloos, P. A. C., Walfridsson, J., Olsson, L., Bukowski, J.-P., Johansen, J. V., Bak, M., Tommerup, N., Rappsilber, J., & Helin, K. (2010) · Nature · doi:10.1038/nature08788 · Cited by 561 · cited 1×
“The upregulation of many PRC target genes leads to global epigenetic changes [209–211].”
BackgroundAlveolar Cell Senescence in Patients with Pulmonary Emphysema
Tsuji, T., Aoshiba, K., & Nagai, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1374oc · Cited by 527 · cited 1×
“Emphysema Telomere length, IGFBP-3, IGFBP-rP1, p16INK4a, and p21 [194, 195]”
Nox enzymes and new thinking on reactive oxygen: A double-edged sword revisited
Lambeth, J. D., & Neish, A. S. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104651 · Cited by 495 · cited 1×
“The family comprises seven transmembrane members, namely, Nox1– 5 [13–15] and Duox1-2 [16].”
BackgroundMiñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola, S., Kagerbauer, B., Espinosa-Parrilla, Y., Ferrer, I., Estivill, X., & Martí, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr210 · Cited by 482 · cited 1×
“The human miR-34a is downregulated in Parkinson’s disease brain, while it is upregulated in AD brains [234] and in plasma of Huntington’s disease patients [235].”
BackgroundMovafagh, S., Crook, S., & Vo, K. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25074 · Cited by 469 · cited 1×
“HIF-1a Cell adaption to oxygen tension modifications [52] Cell proliferation; angiogenesis [77] Cell transformation [78, 79]”
De Cecco, M., Criscione, S. W., Peckham, E. J., Hillenmeyer, S., Hamm, E. A., Manivannan, J., Peterson, A. L., Kreiling, J. A., Neretti, N., & Sedivy, J. M. (2013) · Aging Cell · doi:10.1111/acel.12047 · Cited by 459 · cited 1×
“The upregulation of many PRC target genes leads to global epigenetic changes [209–211].”
BackgroundMagenta, A., Cencioni, C., Fasanaro, P., Zaccagnini, G., Greco, S., Sarra-Ferraris, G., Antonini, A., Martelli, F., & Capogrossi, M. C. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.42 · Cited by 457 · cited 4×
“Also, miR-200 family has been extensively studied in epithelial-to-mesenchymal transition of cancer cells [236].”
BackgroundInfluentialImmune mechanisms linked to depression via oxidative stress and neuroprogression
Bakunina, N., Pariante, C. M., & Zunszain, P. A. (2015) · Immunology · doi:10.1111/imm.12443 · Cited by 444 · cited 2×
“ROS is integral in the development of physiopathologic events like mitochondrial death signaling [86] and autophagy [87], besides inflammation and infection [55, 88], in which they impart immunological changes.”
BackgroundExposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase
Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E. R., & Abraham, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143685 · Cited by 441 · cited 1×
“AMP-activated protein kinases (AMPK) (i) Regulation of cell ROS/redox balance [41, 42] Myocyte adaptation to energy requirement [42] Adipocyte differentiation [58] Lipid metabolism (“fatty liver”) [59] Hyperglycemic damage [60] Cell fate (autophagy and apoptosis) [61]”
BackgroundRoberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428 · cited 4×
“Large and flat shape, rich cytoplasmic and vacuolar granularity, high levels of lysosomal 𝛽-galactosidase activity (SA-𝛽gal), p16, p21, macroH2A, IL-6, phosphorylated p38MAPK, and “double-strand breaks” are the most common senescent cells features in in situ assays [9].”
InfluentialAgger, K., Cloos, P. A. C., Rudkjær, L., Williams, K., Andersen, G., Christensen, J., & Helin, K. (2009) · Genes & Development · doi:10.1101/gad.510809 · Cited by 427
ROS and Brain Diseases: The Good, the Bad, and the Ugly
Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427 · cited 1×
“PPARγ (i) Redox sensor function [43] (ii) Regulation of genes that modulate ROS increases [44] Neurodegenerative diseases [65, 66] Lipid dysfunction (fatty liver) [59]”
BackgroundFree Radicals in Cross Talk Between Autophagy and Apoptosis
Kaminskyy, V. O., & Zhivotovsky, B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5746 · Cited by 412 · cited 2×
“AMP-activated protein kinases (AMPK) (i) Regulation of cell ROS/redox balance [41, 42] Myocyte adaptation to energy requirement [42] Adipocyte differentiation [58] Lipid metabolism (“fatty liver”) [59] Hyperglycemic damage [60] Cell fate (autophagy and apoptosis) [61]”
BackgroundArcher, S. L., Marsboom, G., Kim, G. H., Zhang, H. J., Toth, P. T., Svensson, E. C., Dyck, J. R. B., Gomberg-Maitland, M., Thébaud, B., Husain, A. N., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.916098 · Cited by 407 · cited 2×
“The data on OS-mediated alterations in DNA methylation, which have been so far obtained, motivate chemoprevention trials, to reduce OS in cancer diseases [141–143].”
BackgroundCellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394 · cited 2×
“Melanoma SA-βgal, p16, and p21 [179]”
BackgroundDual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
Rader, J., Russell, M. R., Hart, L. S., Nakazawa, M. S., Belcastro, L. T., Martinez, D., Li, Y., Carpenter, E. L., Attiyeh, E. F., Diskin, S. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1675 · Cited by 394
Senescent cells harbour features of the cancer epigenome
Cruickshanks, H. A., McBryan, T., Nelson, D. M., VanderKraats, N. D., Shah, P. P., van Tuyn, J., Singh Rai, T., Brock, C., Donahue, G., Dunican, D. S., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2879 · Cited by 358 · cited 2×
“The cellular senescence process is considered an aging hallmark, because it drives the cells through longevity, by hampering tumorigenesis and cell death, and is involved in many age-related diseases [97, 205, 206].”
BackgroundThe microRNA miR-34 modulates ageing and neurodegeneration in Drosophila
Liu, N., Landreh, M., Cao, K., Abe, M., Hendriks, G.-J., Kennerdell, J. R., Zhu, Y., Wang, L.-S., & Bonini, N. M. (2012) · Nature · doi:10.1038/nature10810 · Cited by 356 · cited 2×
“All these events have been associated with cell senescence [203, 231, 232].”
BackgroundMitochondrial effectors of cellular senescence: beyond the free radical theory of aging
Ziegler, D. V., Wiley, C. D., & Velarde, M. C. (2015) · Aging Cell · doi:10.1111/acel.12287 · Cited by 354 · cited 3×
“Themolecules secreted by senescent cells (secretoma) cooperate deeply to maintain the tissues homeostasis, through autocrine and paracrine activities [151], by acting at multiple levels: epigenome [152], gene expression, protein processing, and metabolic control [153].”
BackgroundHistone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
Barradas, M., Anderton, E., Acosta, J. C., Li, S., Banito, A., Rodriguez-Niedenführ, M., Maertens, G., Banck, M., Zhou, M.-M., Walsh, M. J., et al. (2009) · Genes & Development · doi:10.1101/gad.511109 · Cited by 352
Cellular senescence and organismal aging
Jeyapalan, J. C., & Sedivy, J. M. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.001 · Cited by 346 · cited 2×
“An increased senescence secretoma causes detrimental effects over the years and contributes to the typical disruption of aged tissues [8, 167, 168].”
BackgroundEpigenetics, oxidative stress, and Alzheimer disease
Zawia, N. H., Lahiri, D. K., & Cardozo-Pelaez, F. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.006 · Cited by 337 · cited 1×
“These regions have been demonstrated to hit gene expression and DNA susceptibility to damage in Alzheimer’s pathology [149].”
BackgroundProtecting the mitochondrial powerhouse
Scheibye-Knudsen, M., Fang, E. F., Croteau, D. L., Wilson, D. M., & Bohr, V. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.002 · Cited by 334 · cited 1×
“Mitochondrial ROS may activate an adaptive response (mitohormesis), which, as defensive mechanism, promotes health to extend the lifespan through diseases prevention and delay [5, 85].”
BackgroundA mitochondrial superoxide theory for oxidative stress diseases and aging
Indo, H. P., Yen, H.-C., Nakanishi, I., Matsumoto, K.-I., Tamura, M., Nagano, Y., Matsui, H., Gusev, O., Cornette, R., Okuda, T., et al. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-42 · Cited by 334 · cited 1×
“For example, mitochondria-nucleus interplay [101] and alterations of mitochondrial homeostasis drive age-dependent modifications [102, 103].”
BackgroundForkhead Homeobox Type O Transcription Factors in the Responses to Oxidative Stress
Storz, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3405 · Cited by 333 · cited 1×
“Nrf2 Cell adaptation to ROS resistance [49, 50] Apoptosis [70] Neurodegenerative diseases [71] Cardiovascular diseases [72]”
BackgroundSalminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333 · cited 2×
“Alzheimer’s disease SA-β-gal [189, 190]”
BackgroundReplicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas
Paradis, V., Youssef, N., Dargère, D., Bâ, N., Bonvoust, F., Deschatrette, J., & Bedossa, P. (2001) · Human Pathology · doi:10.1053/hupa.2001.22747 · Cited by 314
Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells
Cannito, S., Novo, E., Compagnone, A., Valfrè di Bonzo, L., Busletta, C., Zamara, E., Paternostro, C., Povero, D., Bandino, A., Bozzo, F., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn216 · Cited by 309 · cited 1×
“HIF-1a Cell adaption to oxygen tension modifications [52] Cell proliferation; angiogenesis [77] Cell transformation [78, 79]”
Redox regulation of protein kinases
Corcoran, A., & Cotter, T. G. (2013) · The FEBS Journal · doi:10.1111/febs.12224 · Cited by 306
Role of redox-regulated transcription factors in inflammation, aging and age-related diseases
Lavrovsky, Y. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00118-2 · Cited by 304 · cited 1×
“NF-κB Regulation of redox-sensitive gene expression [54, 55] Rheumatoid arthritis, dyslipidemia, atherosclerosis, and insulin resistance [81]”
BackgroundThangavel, C., Dean, J. L., Ertel, A., Knudsen, K. E., Aldaz, C. M., Witkiewicz, A. K., Clarke, R., & Knudsen, E. S. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0262 · Cited by 302 · cited 1×
“Breast cancer SA-βgal, p21, p16, DEP1, NTAL, EBP50, STX4, VAMP3, ARMX3, B2MG, LANCL1, VPS26A, and PLD3 [174, 175]”
Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression
Kietzmann, T., & Görlach, A. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.010 · Cited by 295 · cited 2×
“FOXO3A Cell coordination in response to OS [51] Metabolic adaptation to low nutrient intake [73] Cancer development [73] Diabetes [74] Atherosclerotic cardiovascular disease [75]”
BackgroundTumor suppressor genes and ROS: complex networks of interactions
Vurusaner, B., Poli, G., & Basaga, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.035 · Cited by 293 · cited 1×
“ROS may modulate tumor suppression process, which is induced by the senescence, thus participating in anticancer mechanisms, although ROS may act as tumor promoters in definite conditions [48].”
BackgroundROS-Mediated DNA Methylation Pattern Alterations in Carcinogenesis
Wu, Q., & Ni, X. (2015) · Current Drug Targets · doi:10.2174/1389450116666150113121054 · Cited by 292 · cited 2×
“Tumor progression is induced by general hypomethylation of theDNA and hypermethylation of tumor suppressor genes that lead to aberrant genes expression [138–140].”
BackgroundSenescent Cells: A Novel Therapeutic Target for Aging and Age-Related Diseases
Naylor, R. M., Baker, D. J., & van Deursen, J. M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.193 · Cited by 280 · cited 2×
“Senescent cells endowed with the semiselective marker of senescence p16 drive age-related pathologies, which are delayed or prevented by the selective elimination of the senescent cells [169].”
BackgroundAgeing, oxidative stress and cancer: paradigms in parallax
Benz, C. C., & Yau, C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2522 · Cited by 278
Manganese Superoxide Dismutase and Oxidative Stress Modulation
(2015) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2014.11.001 · Cited by 274 · cited 1×
“Endogenous antioxidants, like the enzymes of catalase family, glutathione group, thioredoxin-related group, and superoxide dismutase [18], together with exogenous antioxidant as reduced glutathione [19], carotenoids, and vitamins C and E, constitute the indispensable ROS detoxifying system.”
BackgroundMitochondria, Energetics, Epigenetics, and Cellular Responses to Stress
Shaughnessy, D. T., McAllister, K., Worth, L., Haugen, A. C., Meyer, J. N., Domann, F. E., Van Houten, B., Mostoslavsky, R., Bultman, S. J., Baccarelli, A. A., et al. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1408418 · Cited by 268 · cited 2×
“ROS operate modifications on histone and DNA, by acting in interconnected epigenetic phases, during mitochondrial and nuclear DNA regulation [125, 126].”
BackgroundFree radical biology for medicine: learning from nonalcoholic fatty liver disease
Serviddio, G., Bellanti, F., & Vendemiale, G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.174 · Cited by 267 · cited 2×
“PPARγ (i) Redox sensor function [43] (ii) Regulation of genes that modulate ROS increases [44] Neurodegenerative diseases [65, 66] Lipid dysfunction (fatty liver) [59]”
BackgroundThe role of mitochondrial DNA mutations and free radicals in disease and ageing
Lagouge, M., & Larsson, N. ‐. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12055 · Cited by 266 · cited 1×
“The errors in mtDNA replication and repair, which accumulate through clonal expansion in advanced age, result in amajor source ofmtDNAmutations, rather than the errors acquired through ROS-dependent vicious cycles [116].”
BackgroundTelomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265 · cited 1×
“Emphysema Telomere length, IGFBP-3, IGFBP-rP1, p16INK4a, and p21 [194, 195]”
Mitochondrial hTERT exacerbates free‐radical‐mediated mtDNA damage
Santos, J. H., Meyer, J. N., Skorvaga, M., Annab, L. A., & Van Houten, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00124.x · Cited by 264
Characterization of novel markers of senescence and their prognostic potential in cancer
Althubiti, M., Lezina, L., Carrera, S., Jukes-Jones, R., Giblett, S. M., Antonov, A., Barlev, N., Saldanha, G. S., Pritchard, C. A., Cain, K., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.489 · Cited by 256 · cited 1×
“Breast cancer SA-βgal, p21, p16, DEP1, NTAL, EBP50, STX4, VAMP3, ARMX3, B2MG, LANCL1, VPS26A, and PLD3 [174, 175]”
Indran, I. R., Hande, M. P., & Pervaiz, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1588 · Cited by 256 · cited 1×
“Various observations demonstrate that hTERT may confer major sensitivity towards OS [144] and reduce ROS increase in aging and age-related diseases [145].”
BackgroundReconfiguration of DNA methylation in aging
Zampieri, M., Ciccarone, F., Calabrese, R., Franceschi, C., Bürkle, A., & Caiafa, P. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.02.002 · Cited by 254
AMP-activated protein kinase, stress responses and cardiovascular diseases
Wang, S., Song, P., & Zou, M.-H. (2012) · Clinical Science · doi:10.1042/cs20110625 · Cited by 245 · cited 1×
“AMP-activated protein kinases (AMPK) (i) Regulation of cell ROS/redox balance [41, 42] Myocyte adaptation to energy requirement [42] Adipocyte differentiation [58] Lipid metabolism (“fatty liver”) [59] Hyperglycemic damage [60] Cell fate (autophagy and apoptosis) [61]”
BackgroundCell Senescence: Role in Aging and Age-Related Diseases
Campisi, J., & Robert, L. (2014) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000358899 · Cited by 240 · cited 2×
“An increased senescence secretoma causes detrimental effects over the years and contributes to the typical disruption of aged tissues [8, 167, 168].”
BackgroundThe effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid.
Korbecki, J., Baranowska‐Bosiacka, I., Gutowska, I., & Chlubek, D. (2013) · PubMed · Cited by 240
Nongenetic inheritance and transgenerational epigenetics
Szyf, M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.12.004 · Cited by 238 · cited 2×
“Intra- and extracellular environments change hereditary characters at the epigenetic level, without altering genes sequence [122].”
BackgroundAntioxidant supplements and mortality
Bjelakovic, G., Nikolova, D., & Gluud, C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000009 · Cited by 234
The influence of reactive oxygen species on cell cycle progression in mammalian cells
Verbon, E. H., Post, J. A., & Boonstra, J. (2012) · Gene · doi:10.1016/j.gene.2012.08.038 · Cited by 233 · cited 2×
“effects on cellular proliferation, mutagenesis, and apoptosis inhibition [56].”
BackgroundMitochondrial DNA methylation as a next-generation biomarker and diagnostic tool
Iacobazzi, V., Castegna, A., Infantino, V., & Andria, G. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.07.012 · Cited by 230 · cited 2×
“The data on OS-mediated alterations in DNA methylation, which have been so far obtained, motivate chemoprevention trials, to reduce OS in cancer diseases [141–143].”
BackgroundRedox signaling in cardiovascular health and disease
Madamanchi, N. R., & Runge, M. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.001 · Cited by 228 · cited 2×
“Receptor-dependent or nondependent tyrosine kinases, AMP-activated protein kinases, adaptor protein p66SHC, and transcription factors as FOXO (forkhead homeobox type O), Nrf2 (nuclear factor E2-related factor 2), p53 (tumor suppressor 53), NFκB (nuclear factor kappa B), AP-1 (activator protein-1), HIF-1a (hypoxia indu…”
BackgroundRegulation of intracellular signalling through cysteine oxidation by reactive oxygen species
Miki, H., & Funato, Y. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs006 · Cited by 225 · cited 1×
“A wide range of pathways and molecular mechanisms that involve ROS suggests determining the redox state of thiols in ROS targets, which compose the “cellular oxidative interface” [32, 33].”
BackgroundOxidative Stress and Epigenetic Regulation in Ageing and Age-Related Diseases
Cencioni, C., Spallotta, F., Martelli, F., Valente, S., Mai, A., Zeiher, A., & Gaetano, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917643 · Cited by 223 · cited 5×
“Examples of both ROS levels and DNA methylation, which seems to change with age, suggest that they are potentially linked [146, 147].”
BackgroundInfluentialp53, ROS and senescence in the control of aging
Vigneron, A., & Vousden, K. H. (2010) · Aging · doi:10.18632/aging.100189 · Cited by 221 · cited 4×
“Particular emphasis is addressed to novel mechanism of ROS and epigenetics in cell senescence and aging [160, 165, 166].”
BackgroundInfluentialRedox Regulation of Inflammation: Old Elements, a New Story
Lei, Y., Wang, K., Deng, L., Chen, Y., Nice, E. C., & Huang, C. (2015) · Medicinal Research Reviews · doi:10.1002/med.21330 · Cited by 209 · cited 1×
“ROS is integral in the development of physiopathologic events like mitochondrial death signaling [86] and autophagy [87], besides inflammation and infection [55, 88], in which they impart immunological changes.”
BackgroundCellular responses to reactive oxygen species-induced DNA damage and aging
Bertram, C., & Hass, R. (2008) · bchm · doi:10.1515/bc.2008.031 · Cited by 209 · cited 1×
“Summarizing, ROS are involved in elderly lesions that concern (i) DNA insufficiency, which is partly responsible for premature aging and apoptosis [117]; (ii) RNA involvement in the onset of chronic-degenerative diseases [118]; (iii) nuclear lamins that participate in cell proliferation and longevity [119].”
BackgroundSenescence-associated lncRNAs: senescence-associated long noncoding RNAs
Abdelmohsen, K., Panda, A., Kang, M.-J., Xu, J., Selimyan, R., Yoon, J.-H., Martindale, J. L., De, S., Wood, W. H., Becker, K. G., et al. (2013) · Aging Cell · doi:10.1111/acel.12115 · Cited by 208 · cited 1×
“The senescence-associated lncRNAs are differentially expressed in proliferating and senescent fibroblasts, as assessed by RNA sequencing [224–226].”
BackgroundMitochondrial and Cytoplasmic ROS Have Opposing Effects on Lifespan
Schaar, C. E., Dues, D. J., Spielbauer, K. K., Machiela, E., Cooper, J. F., Senchuk, M., Hekimi, S., & Van Raamsdonk, J. M. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004972 · Cited by 203 · cited 1×
“OS effect on worms’ lifespan depends on where ROS are produced: high mitochondrial or cytoplasmic levels are associated with increased and decreased lifespan, respectively [109, 112].”
BackgroundLong noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit
Puvvula, P. K., Desetty, R. D., Pineau, P., Marchio, A., Moon, A., Dejean, A., & Bischof, O. (2014) · Nature Communications · doi:10.1038/ncomms6323 · Cited by 200 · cited 1×
“Specific transcription factors [212], as well as long noncoding RNAs [213], are involved in the recruitment performed by PRC.”
BackgroundYanai, H., Shteinberg, A., Porat, Z., Budovsky, A., Braiman, A., Zeische, R., & Fraifeld, V. E. (2015) · Aging · doi:10.18632/aging.100807 · Cited by 198 · cited 4×
“Idiopathic pulmonary fibrosis Telomeres length, IGFBP5, and SA-βgal [183, 184]”
BackgroundInfluentialThe Mitochondrial Free Radical Theory of Aging
Barja, G. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394625-6.00001-5 · Cited by 193 · cited 1×
“A progressive ROS scavengers decrease shifts aged cells towards a prooxidant status [105, 106].”
BackgroundRole of Forkhead Transcription Factors in Diabetes-Induced Oxidative Stress
Ponugoti, B., Dong, G., & Graves, D. T. (2012) · Experimental Diabetes Research · doi:10.1155/2012/939751 · Cited by 189 · cited 1×
“FOXO3A Cell coordination in response to OS [51] Metabolic adaptation to low nutrient intake [73] Cancer development [73] Diabetes [74] Atherosclerotic cardiovascular disease [75]”
BackgroundMicroRNAs in age‐related diseases
Dimmeler, S., & Nicotera, P. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201986 · Cited by 188 · cited 1×
“Among short ncRNAs, the microRNAs (miRNAs) have emerged as being able to control the gene expression, either by blocking targeted mRNA translation or by mRNA degrading [220, 221].”
BackgroundRedox Regulation of p53, Redox Effectors Regulated by p53: A Subtle Balance
Maillet, A., & Pervaiz, S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4434 · Cited by 186 · cited 1×
“p53 Modulation of cell redox balance (prooxidant/antioxidant effects) [46–48] Cell fate signaling [68] Autophagy and apoptosis [61, 69]”
BackgroundComing of age: molecular drivers of aging and therapeutic opportunities
Newgard, C. B., & Sharpless, N. E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68833 · Cited by 184 · cited 1×
“The general consensus on cellular damage accumulation, as aging initial event, suggests that cell senescence process is a major question regarding biological and clinical aging aspects [10].”
BackgroundCossarizza, A., Ferraresi, R., Troiano, L., Roat, E., Gibellini, L., Bertoncelli, L., Nasi, M., & Pinti, M. (2009) · Nature Protocols · doi:10.1038/nprot.2009.189 · Cited by 183 · cited 1×
“An innovative method simultaneously assesses glutathione, hydrogen peroxide, and superoxide levels in a single cell, together with cell viability alterations, thus allowing for defining both oxidant-antioxidant balance and cell death, after the administration of a specific stimulus [31].”
MethodA ROS rheostat for cell fate regulation
Maryanovich, M., & Gross, A. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.09.007 · Cited by 182 · cited 1×
“Intrinsic and extrinsic factors control ROS regulation on cellular selfrenewal, quiescence, senescence, and apoptosis, during the in vivo tissues homeostasis and repair [83] and in ROS”
BackgroundDNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease
Birch, J., Anderson, R. K., Correia-Melo, C., Jurk, D., Hewitt, G., Marques, F. M., Green, N. J., Moisey, E., Birrell, M. A., Belvisi, M. G., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00293.2015 · Cited by 174 · cited 2×
“Chronic obstructive pulmonary disease Telomere length, p16, p21, and SA-βgal [191, 192]”
BackgroundChoi, J., Shendrik, I., Peacocke, M., Peehl, D., Buttyan, R., Ikeguchi, E. F., Katz, A. E., & Benson, M. C. (2000) · Urology · doi:10.1016/s0090-4295(00)00538-0 · Cited by 173 · cited 4×
“Benign prostatic hyperplasia SA-βgal [196, 197]”
InfluentialNoureddine, H., Gary-Bobo, G., Alifano, M., Marcos, E., Saker, M., Vienney, N., Amsellem, V., Maitre, B., Chaouat, A., Chouaid, C., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.241299 · Cited by 173 · cited 2×
“Pulmonary hypertension p16, p21 [192, 193]”
BackgroundZhang, Y., Ikeno, Y., Qi, W., Chaudhuri, A., Li, Y., Bokov, A., Thorpe, S. R., Baynes, J. W., Epstein, C., Richardson, A., et al. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp132 · Cited by 172
Redox regulation of protein kinases
Truong, T. H., & Carroll, K. S. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.790873 · Cited by 169
Positive oxidative stress in aging and aging-related disease tolerance
Yan, L.-J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.002 · Cited by 169 · cited 1×
“Low ROS levels improve the defense mechanisms by inducing adaptive responses, which contributes to stress resistance and longevity, while high ROS levels induce insufficient adaptive responses, which may contribute to aging onset and progression [121].”
BackgroundPhysiological roles of long noncoding RNAs: insight from knockout mice
Li, L., & Chang, H. Y. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.06.003 · Cited by 167 · cited 1×
“Recently, ncRNA role is gaining more importance in age-associated dysfunctions as cardiovascular diseases [222, 223].”
BackgroundWerner, C. A. (2010) · Cited by 165
Zhou, X., Kwon, Y., Kim, G., Ryu, J.-H., & Yoon, J. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.08.089 · Cited by 163 · cited 1×
“Probes and antibodies have been developed to recognize oxidative damage by ROS/RNS [23–25].”
BackgroundDetection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid
Poulsen, H. E., Nadal, L. L., Broedbaek, K., Nielsen, P. E., & Weimann, A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.009 · Cited by 162 · cited 1×
“The tools allow revealing antioxidant enzymes [26] and a variety of oxidative products, as lipid peroxidation products, protein carbonyls [27], oxidized DNA products [28], and nitrotyrosine [29].”
BackgroundFrom Sulfenylation to Sulfhydration: What a Thiolate Needs to Tolerate
Finkel, T. (2012) · Science Signaling · doi:10.1126/scisignal.2002943 · Cited by 161 · cited 1×
“This molecule functions as OS/NS sensor within enzymes and transcriptional regulatory factors and may allow priming the routes of the versatile ROS action [34–36].”
BackgroundMitochondria: Are they causal players in cellular senescence?
Correia-Melo, C., & Passos, J. F. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.017 · Cited by 160
The role of tumor suppressor p53 in the antioxidant defense and metabolism
Budanov, A. V. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_18 · Cited by 157 · cited 1×
“Intrinsic and extrinsic events can induce either the cell senescence or the apoptosis process, depending on the level of the impairment of the cell homeostasis [150] and the p53 activity [47].”
BackgroundBianchessi, V., Badi, I., Bertolotti, M., Nigro, P., D’Alessandra, Y., Capogrossi, M. C., Zanobini, M., Pompilio, G., Raucci, A., & Lauri, A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.012 · Cited by 156 · cited 1×
“A mitochondrialtranscribed lncRNA is induced in aorta and endothelial cells aging, during the “replicative vascular senescence,” which is partly responsible for age-associated cardiovascular diseases, but not in the “stress-induced premature senescence” by ROS [228].”
BackgroundAge-associated changes in expression of small, noncoding RNAs, including microRNAs, in C. elegans
Kato, M., Chen, X., Inukai, S., Zhao, H., & Slack, F. J. (2011) · RNA · doi:10.1261/rna.2714411 · Cited by 156 · cited 2×
“All these events have been associated with cell senescence [203, 231, 232].”
BackgroundFree radical biology of the cardiovascular system
Chen, A. F., Chen, D.-D., Daiber, A., Faraci, F. M., Li, H., Rembold, C. M., & Laher, I. (2012) · Clinical Science · doi:10.1042/cs20110562 · Cited by 152 · cited 1×
“PPARγ (i) Redox sensor function [43] (ii) Regulation of genes that modulate ROS increases [44] Neurodegenerative diseases [65, 66] Lipid dysfunction (fatty liver) [59]”
BackgroundEpigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis
Nanduri, J., Makarenko, V. V., Reddy, V. D., Yuan, G., Pawar, A., Wang, N., Khan, S. A., Zhang, X., Kinsman, B. J., Peng, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120600109 · Cited by 146 · cited 2×
“Treatments with DNA methylation inhibitors, in preclinical studies, can prevent the hypoxic sensitivity that leads to the respiratory dysfunction [148].”
BackgroundHsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.
Gaughwin, P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., & Björkqvist, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr111 · Cited by 145 · cited 1×
“The human miR-34a is downregulated in Parkinson’s disease brain, while it is upregulated in AD brains [234] and in plasma of Huntington’s disease patients [235].”
BackgroundExpression of Chr9p21 genes CDKN2B (p15), CDKN2A (p16, p14) and MTAP in human atherosclerotic plaque
Holdt, L. M., Sass, K., Gäbel, G., Bergert, H., Thiery, J., & Teupser, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.029 · Cited by 143 · cited 1×
“Aged vascular tissues Telomeres length, SA-βGal, p16, and p21 [170, 171]”
Background7SL RNA represses p53 translation by competing with HuR
Abdelmohsen, K., Panda, A. C., Kang, M.-J., Guo, R., Kim, J., Grammatikakis, I., Yoon, J.-H., Dudekula, D. B., Noh, J. H., Yang, X., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku686 · Cited by 139
Oxidative stress: A cause and therapeutic target of diabetic complications
Araki, E., & Nishikawa, T. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00013.x · Cited by 138 · cited 1×
“AMP-activated protein kinases (AMPK) (i) Regulation of cell ROS/redox balance [41, 42] Myocyte adaptation to energy requirement [42] Adipocyte differentiation [58] Lipid metabolism (“fatty liver”) [59] Hyperglycemic damage [60] Cell fate (autophagy and apoptosis) [61]”
BackgroundRoles of DUOX-Mediated Hydrogen Peroxide in Metabolism, Host Defense, and Signaling
De Deken, X., Corvilain, B., Dumont, J. E., & Miot, F. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5602 · Cited by 138
Histone Modifications in Senescence-Associated Resistance to Apoptosis by Oxidative Stress
Sanders, Y. Y., Liu, H., Zhang, X., Hecker, L., Bernard, K., Desai, L., Liu, G., & Thannickal, V. J. (2013) · Redox Biology · doi:10.1016/j.redox.2012.11.004 · Cited by 138 · cited 1×
“Themolecules secreted by senescent cells (secretoma) cooperate deeply to maintain the tissues homeostasis, through autocrine and paracrine activities [151], by acting at multiple levels: epigenome [152], gene expression, protein processing, and metabolic control [153].”
BackgroundNitric Oxide Physiology and Pathology
Hirst, D. G., & Robson, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-61737-964-2_1 · Cited by 136
Radical Oxygen Species, Exercise and Aging: An Update
Bouzid, M. A., Filaire, E., McCall, A., & Fabre, C. (2015) · Sports Medicine · doi:10.1007/s40279-015-0348-1 · Cited by 133 · cited 1×
“On the other hand, acute exercise increases ROS production and damage from ROS [108].”
BackgroundHawkes, H.-J. K., Karlenius, T., & Tonissen, K. F. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.013 · Cited by 133 · cited 2×
“Receptor-dependent or nondependent tyrosine kinases, AMP-activated protein kinases, adaptor protein p66SHC, and transcription factors as FOXO (forkhead homeobox type O), Nrf2 (nuclear factor E2-related factor 2), p53 (tumor suppressor 53), NFκB (nuclear factor kappa B), AP-1 (activator protein-1), HIF-1a (hypoxia indu…”
BackgroundOxidative Stress in Cardiovascular Diseases and Obesity: Role of p66Shc and Protein Kinase C
De Marchi, E., Baldassari, F., Bononi, A., Wieckowski, M. R., & Pinton, P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/564961 · Cited by 132 · cited 2×
“Receptor-dependent or nondependent tyrosine kinases, AMP-activated protein kinases, adaptor protein p66SHC, and transcription factors as FOXO (forkhead homeobox type O), Nrf2 (nuclear factor E2-related factor 2), p53 (tumor suppressor 53), NFκB (nuclear factor kappa B), AP-1 (activator protein-1), HIF-1a (hypoxia indu…”
Background8-Hydroxy-2′-Deoxyguanosine and Cardiovascular Disease: a Systematic Review
Kroese, L. J., & Scheffer, P. G. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0452-y · Cited by 131 · cited 1×
“Also, the oxidation of deoxy-guanine of CpG nucleotides to 8-hydroxy-2-deoxyguanosine (8-OHdG) is believed to be a surrogate marker of oxidative damage, in various human diseases [131].”
BackgroundMitochondria as a Target in the Therapeutic Properties of Curcumin
Trujillo, J., Granados‐Castro, L. F., Zazueta, C., Andérica‐Romero, A. C., Chirino, Y. I., & Pedraza‐Chaverrí, J. (2014) · Archiv der Pharmazie · doi:10.1002/ardp.201400266 · Cited by 129
Protein modification and replicative senescence of WI‐38 human embryonic fibroblasts
Ahmed, E. K., Rogowska‐Wrzesinska, A., Roepstorff, P., Bulteau, A., & Friguet, B. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00555.x · Cited by 129 · cited 2×
“The autophagy inhibition causes the senescent cells to aggregate oxidized proteins and protein carbonyls with products of lipid peroxidation and protein glycation into the lipofuscin [158].”
BackgroundThe emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses
Weyemi, U., & Dupuy, C. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.04.002 · Cited by 127
Genetic factors associated with longevity: A review of recent findings
Shadyab, A. H., & LaCroix, A. Z. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.005 · Cited by 126 · cited 1×
“Some theories associate various factors with aging rate, as changes of metabolic control [2] and gene expression patterns [3] and production of high levels of Reactive Oxygen Species (ROS) [4].”
BackgroundThe Interplay Between Respiratory Supercomplexes and ROS in Aging
Genova, M. L., & Lenaz, G. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6214 · Cited by 126
Nitric Oxide, Oxidative Stress, and p66Shc Interplay in Diabetic Endothelial Dysfunction
Magenta, A., Greco, S., Capogrossi, M. C., Gaetano, C., & Martelli, F. (2014) · BioMed Research International · doi:10.1155/2014/193095 · Cited by 125 · cited 2×
“Receptor-dependent or nondependent tyrosine kinases, AMP-activated protein kinases, adaptor protein p66SHC, and transcription factors as FOXO (forkhead homeobox type O), Nrf2 (nuclear factor E2-related factor 2), p53 (tumor suppressor 53), NFκB (nuclear factor kappa B), AP-1 (activator protein-1), HIF-1a (hypoxia indu…”
BackgroundAfanas’ev, I. (2014) · Aging and Disease · doi:10.14336/ad.2014.050052 · Cited by 125 · cited 4×
“The histone demethylases network is often synergizing with the action of histone deacetylases, histone methyl transferases, and various nuclear transcriptional complexes, thus ensuring that the chromatinic environment is correct for the cell [128, 146].”
BackgroundInfluentialROS and energy metabolism in cancer cells: alliance for fast growth
Kang, S. W., Lee, S., & Lee, E. K. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0550-6 · Cited by 123 · cited 1×
“OS is allied with energy metabolism to stimulate the growth of cells transformed by oncogenes or tumor suppressors [92–94].”
BackgroundApoptosis and Aging: Role of p66 Shc Redox Protein
Migliaccio, E., Giorgio, M., & Pelicci, P. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.600 · Cited by 123 · cited 1×
“Prolonged life span [43, 62] Cardiovascular diseases and obesity [63] Diabetic endothelial dysfunction [64]”
BackgroundEpigenomes as therapeutic targets
Hamm, C. A., & Costa, F. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.003 · Cited by 123 · cited 1×
“These features suggest epigenetic modifications as more attractive target for therapeutic interventions in humans than genetic modification, throughout the entire life [124].”
BackgroundAntioxidants in health and disease
GINTER, E., SIMKO, V., & Panakova, V. (2014) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2014_116 · Cited by 121
Noncoding RNA in age-related cardiovascular diseases
Greco, S., Gorospe, M., & Martelli, F. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.011 · Cited by 120 · cited 2×
“The event may activate aberrant pathways and also aging mechanism in young individuals [222].”
BackgroundConfining euchromatin/heterochromatin territory: jumonji crosses the line
Tamaru, H. (2010) · Genes & Development · doi:10.1101/gad.1941010 · Cited by 118 · cited 2×
“Indeed, the epigenetic modulation provides the essential and flexible interface between the organisms and the environment, which results in being essential for all the cell functions [122, 123, 129], throughout the lifespan [135–137].”
BackgroundMass spectrometry and redox proteomics: Applications in disease
Butterfield, D. A., Gu, L., Domenico, F. D., & Robinson, R. A. S. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21374 · Cited by 115
Byun, H.-O., Lee, Y.-K., Kim, J.-M., & Yoon, G. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.10.122 · Cited by 115 · cited 1×
“An increased senescence secretoma causes detrimental effects over the years and contributes to the typical disruption of aged tissues [8, 167, 168].”
BackgroundThe emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 113 · cited 1×
“Themolecules secreted by senescent cells (secretoma) cooperate deeply to maintain the tissues homeostasis, through autocrine and paracrine activities [151], by acting at multiple levels: epigenome [152], gene expression, protein processing, and metabolic control [153].”
BackgroundProspective Treatment of Age-Related Diseases by Slowing Down Aging
Blagosklonny, M. V. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.024 · Cited by 113 · cited 2×
“Healthy aging appears to be an ideal healthcare priority that entails a better understanding of aging, with the aim of slowing down the process and preventing or even treating its related pathologies [200].”
BackgroundTheories of Aging: An Ever-Evolving Field
Sergiev, P. V., Dontsova, O. A., & Berezkin, G. V. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-1-9-18 · Cited by 112 · cited 1×
“Some theories associate various factors with aging rate, as changes of metabolic control [2] and gene expression patterns [3] and production of high levels of Reactive Oxygen Species (ROS) [4].”
BackgroundCaveolin-1, cellular senescence and age-related diseases
Zou, H., Stoppani, E., Volonte, D., & Galbiati, F. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.11.001 · Cited by 112 · cited 2×
“The upregulation of the Cav1 promoter by high ROS levels contributes to explaining how OS promotes cell senescence effects in aging and age-related diseases [198].”
BackgroundKim, D., Kim, G., Nam, S., Yin, J., & Yoon, J. (2015) · Scientific Reports · doi:10.1038/srep08488 · Cited by 112 · cited 1×
“Probes and antibodies have been developed to recognize oxidative damage by ROS/RNS [23–25].”
BackgroundCellular Mechanisms of Oxidative Stress and Action in Melanoma
Venza, M., Visalli, M., Beninati, C., De Gaetano, G. V., Teti, D., & Venza, I. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/481782 · Cited by 108 · cited 2×
“The data on OS-mediated alterations in DNA methylation, which have been so far obtained, motivate chemoprevention trials, to reduce OS in cancer diseases [141–143].”
BackgroundStem Cells, Redox Signaling, and Stem Cell Aging
Liang, R., & Ghaffari, S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5300 · Cited by 106 · cited 2×
“Recently, interest has been focused on stem cells, because their decline impairs tissues homeostasis maintenance, leading to the organism weakening and the age-related diseases [84].”
BackgroundCastro, P., Xia, C., Gomez, L., Lamb, D. J., & Ittmann, M. (2004) · The Prostate · doi:10.1002/pros.20051 · Cited by 106 · cited 4×
“Benign prostatic hyperplasia SA-βgal [196, 197]”
InfluentialRedox Regulation of Protein Kinases as a Modulator of Vascular Function
Knock, G. A., & Ward, J. P. T. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3614 · Cited by 104 · cited 1×
“Receptor/nonreceptor tyrosine kinases (Src, TRK, AKT, c-Abl, MAPK, CaMKII, PKG, ATM, and Ask1) (i) Interactions between kinases pathways [38, 39] (ii) Signal of ROS production feedback [40] Control of cell cycle progression [56] Mitosis for anchorage-dependent cells [57] Cellular homeostasis [43, 57]”
BackgroundMin, J. Y., Lim, S.-O., & Jung, G. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.048 · Cited by 101 · cited 2×
“Tumor progression is induced by general hypomethylation of theDNA and hypermethylation of tumor suppressor genes that lead to aberrant genes expression [138–140].”
BackgroundRedox Mechanisms in Regulation of Adipocyte Differentiation: Beyond a General Stress Response
Liu, G.-S., Chan, E., Higuchi, M., Dusting, G., & Jiang, F. (2012) · Cells · doi:10.3390/cells1040976 · Cited by 100 · cited 1×
“AMP-activated protein kinases (AMPK) (i) Regulation of cell ROS/redox balance [41, 42] Myocyte adaptation to energy requirement [42] Adipocyte differentiation [58] Lipid metabolism (“fatty liver”) [59] Hyperglycemic damage [60] Cell fate (autophagy and apoptosis) [61]”
BackgroundNADPH Oxidases as Regulators of Tumor Angiogenesis: Current and Emerging Concepts
Coso, S., Harrison, I., Harrison, C. B., Vinh, A., Sobey, C. G., Drummond, G. R., Williams, E. D., & Selemidis, S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4489 · Cited by 99 · cited 1×
“ROS mediate in vitro response towards intra- and extracellular conditions, such as growth factors, cytokines, nutrients deprivation, andhypoxia, which regulate cell proliferation, differentiation, and apoptosis, besides being important cancer hallmarks [82].”
BackgroundCysteine-mediated redox signalling in the mitochondria
Bak, D. W., & Weerapana, E. (2014) · Molecular BioSystems · doi:10.1039/c4mb00571f · Cited by 99 · cited 1×
“A wide range of pathways and molecular mechanisms that involve ROS suggests determining the redox state of thiols in ROS targets, which compose the “cellular oxidative interface” [32, 33].”
BackgroundRedox Homeostasis and Epigenetics in Non-alcoholic Fatty Liver Disease (NAFLD)
Podrini, C., Borghesan, M., Greco, A., Pazienza, V., Mazzoccoli, G., & Vinciguerra, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319150009 · Cited by 98 · cited 2×
“Altered redox mechanisms mediate the link between increased accumulation of triglycerides in hepatocytes and epigeneticmodifications that are recognized as crucial factors in the pathophysiology of this disease [127].”
BackgroundTherapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97 · cited 1×
“With the cell senescence and aging controlled by cells and cellular environment, the possibility is suggested that the two processes may be subjected to interventional therapies [203, 204].”
BackgroundmiR-9a Minimizes the Phenotypic Impact of Genomic Diversity by Buffering a Transcription Factor
Cassidy, J. J., Jha, A. R., Posadas, D. M., Giri, R., Venken, K. J. T., Ji, J., Jiang, H., Bellen, H. J., White, K. P., & Carthew, R. W. (2013) · Cell · doi:10.1016/j.cell.2013.10.057 · Cited by 96 · cited 1×
“Normal cellular development and homeostasis are under the control of miRNAs, throughout the entire life [229], since miRNAs regulate the gene expression in biological processes as proliferation, development, differentiation, and apoptosis.”
BackgroundTanaka, J., Qiang, L., Banks, A. S., Welch, C. L., Matsumoto, M., Kitamura, T., Ido-Kitamura, Y., DePinho, R. A., & Accili, D. (2009) · Diabetes · doi:10.2337/db09-0167 · Cited by 96
Hypoxia-derived oxidative stress mediates epigenetic repression of PKCɛ gene in foetal rat hearts
Patterson, A. J., Xiao, D., Xiong, F., Dixon, B., & Zhang, L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr322 · Cited by 93
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo
Lechel, A., Satyanarayana, A., Ju, Z., Plentz, R. R., Schaetzlein, S., Rudolph, C., Wilkens, L., Wiemann, S. U., Saretzki, G., Malek, N. P., et al. (2005) · EMBO reports · doi:10.1038/sj.embor.7400352 · Cited by 91 · cited 1×
“Intrinsic and extrinsic events can induce either the cell senescence or the apoptosis process, depending on the level of the impairment of the cell homeostasis [150] and the p53 activity [47].”
BackgroundThe Regulation of Aging and Longevity: A New and Complex Role of p53
Feng, Z., Lin, M., & Wu, R. (2011) · Genes & Cancer · doi:10.1177/1947601911410223 · Cited by 89 · cited 2×
“Particular emphasis is addressed to novel mechanism of ROS and epigenetics in cell senescence and aging [160, 165, 166].”
BackgroundMitochondria in ageing: there is metabolism beyond the ROS
Breitenbach, M., Rinnerthaler, M., Hartl, J., Stincone, A., Vowinckel, J., Breitenbach-Koller, H., & Ralser, M. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12134 · Cited by 88 · cited 1×
“Moreover, a number of ROS-independent mitochondrial dysfunctions appear so involved in aging that doubts arise that OS is the most concrete contributor to fuel aging [115].”
BackgroundExpression of p57KIP2 Potently Blocks the Growth of Human Astrocytomas and Induces Cell Senescence
Tsugu, A., Sakai, K., Dirks, P. B., Jung, S., Weksberg, R., Fei, Y. L., Mondal, S., Ivanchuk, S. M., Ackerley, C. A., Hamel, P. A., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64605-6 · Cited by 86
Phagocyte NADPH oxidase and specific immunity
Cachat, J., Deffert, C., Hugues, S., & Krause, K.-H. (2015) · Clinical Science · doi:10.1042/cs20140635 · Cited by 85 · cited 1×
“High ROS levels are generated by professional cells (lymphocytes, granulocytes, and phagocytes) in defense against microbes [89, 90].”
BackgroundCaliceti, C., Nigro, P., Rizzo, P., & Ferrari, R. (2014) · BioMed Research International · doi:10.1155/2014/318714 · Cited by 84 · cited 2×
“Components in β-catenin/Wnt pathway Regulation of Wnt signaling via nucleoredoxin [76] Early embryonic development [76] Vascular development [45]”
BackgroundWagner, J., Damaschke, N., Yang, B., Truong, M., Guenther, C., McCormick, J., Huang, W., & Jarrard, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124366 · Cited by 83
Byun, H.-O., Lee, Y.-K., Kim, J.-M., & Yoon, G. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.122 · Cited by 83
Aleshin, S. E., Strokin, M., Sergeeva, M. G., & Reiser, G. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.012 · Cited by 82 · cited 2×
“PPARγ (i) Redox sensor function [43] (ii) Regulation of genes that modulate ROS increases [44] Neurodegenerative diseases [65, 66] Lipid dysfunction (fatty liver) [59]”
BackgroundRedox regulation of Wnt signalling via nucleoredoxin
Funato, Y., & Miki, H. (2010) · Free Radical Research · doi:10.3109/10715761003610745 · Cited by 82 · cited 1×
“Components in β-catenin/Wnt pathway Regulation of Wnt signaling via nucleoredoxin [76] Early embryonic development [76] Vascular development [45]”
BackgroundMitochondrial dynamics: orchestrating the journey to advanced age
Biala, A. K., Dhingra, R., & Kirshenbaum, L. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.015 · Cited by 82 · cited 2×
“For example, mitochondria-nucleus interplay [101] and alterations of mitochondrial homeostasis drive age-dependent modifications [102, 103].”
BackgroundProtein carbonylation: Proteomics, specificity and relevance to aging
Cabiscol, E., Tamarit, J., & Ros, J. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21375 · Cited by 81
The mitochondrial genome in aging and senescence
Lauri, A., Pompilio, G., & Capogrossi, M. C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.001 · Cited by 80 · cited 7×
“p53 triggers cell cycle arrest by upregulating p21, which inhibits the cell cycle regulator cyclin-dependent kinases Cdk4 and Cdk2 [159].”
BackgroundInfluentialZhang, R., Zhang, Q., Niu, J., Lu, K., Xie, B., Cui, D., & Xu, S. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.017 · Cited by 80
Mitochondrial responsibility in ageing process: innocent, suspect or guilty
López‐Lluch, G., Santos‐Ocaña, C., Sánchez-Alcázar, J. A., Fernández‐Ayala, D. J. M., Asencio, C., Rodríguez‐Aguilera, J. C., & Navas, P. (2015) · Biogerontology · doi:10.1007/s10522-015-9585-9 · Cited by 76 · cited 1×
“A progressive ROS scavengers decrease shifts aged cells towards a prooxidant status [105, 106].”
BackgroundTelomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential
Adnot, S., Amsellem, V., Boyer, L., Marcos, É., Saker, M., Houssaini, A., Kebe, K., Dagouassat, M., Lipskaia, L., & Boczkowski, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.007 · Cited by 72 · cited 4×
“Chronic obstructive pulmonary disease Telomere length, p16, p21, and SA-βgal [191, 192]”
BackgroundInfluentialFrom anchorage dependent proliferation to survival: Lessons from redox signalling
Chiarugi, P. (2008) · IUBMB Life · doi:10.1002/iub.45 · Cited by 72 · cited 2×
“The deregulated ROS productions in cancer cells and the consequent constitutive OS may cause the cellular invasive phenotype [57].”
BackgroundCauses and Consequences of Age-Related Changes in DNA Methylation: A Role for ROS?
Rang, F. J., & Boonstra, J. (2014) · Biology · doi:10.3390/biology3020403 · Cited by 71 · cited 1×
“Examples of both ROS levels and DNA methylation, which seems to change with age, suggest that they are potentially linked [146, 147].”
BackgroundSidi, R., Pasello, G., Opitz, I., Soltermann, A., Tutic, M., Rehrauer, H., Weder, W., Stahel, R. A., & Felley‐Bosco, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.044 · Cited by 71 · cited 2×
“Mesothelioma SA-βgal, p21 [178]”
BackgroundAnticancer Activity of Green Tea Polyphenols in Prostate Gland
Davalli, P., Rizzi, F., Caporali, A., Pellacani, D., Davoli, S., Bettuzzi, S., Brausi, M. A., & D’Arca, D. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/984219 · Cited by 70 · cited 2×
“Although ROS functions remain difficult to investigate, multiple pharmacological investigations are in progress to maintain ROS homeostasis through both OS decrease and antioxidant defense increase [95, 96].”
BackgroundSelf-citationEpigenetic Genome-Wide Association Methylation in Aging and Longevity
Ben-Avraham, D., Muzumdar, R. H., & Atzmon, G. (2012) · Epigenomics · doi:10.2217/epi.12.41 · Cited by 68 · cited 3×
“Starting from the observation that both defective genome and DNA repair processes promote phenotypes of premature aging, the “aging epigenetics” has been developed as emerging discipline, which concerns genes and processes impacting aging (Figure 1) [135].”
BackgroundMitochondria in health, aging and diseases: the epigenetic perspective
D’Aquila, P., Bellizzi, D., & Passarino, G. (2015) · Biogerontology · doi:10.1007/s10522-015-9562-3 · Cited by 68 · cited 1×
“ROS operate modifications on histone and DNA, by acting in interconnected epigenetic phases, during mitochondrial and nuclear DNA regulation [125, 126].”
BackgroundAbo, M., Minakami, R., Miyano, K., Kamiya, M., Nagano, T., Urano, Y., & Sumimoto, H. (2014) · Analytical Chemistry · doi:10.1021/ac501041w · Cited by 67
Cited by
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
“In the aging process, it has been noticed that high-molecular protein aggregates accumulate in cells (Davalli et al., 2016).”
BackgroundCellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Sulaiman Rahman, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,149
“Research evidence has suggested that the molecular inflammatory process plays a vitally important role during the aging process and age-related diseases (Davalli et al., 2016).”
BackgroundReactive Oxygen Species: Drivers of Physiological and Pathological Processes
Checa, J., & Aran, J. M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s275595 · Cited by 984
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 810
Metadata
- Authors
- Davalli, P., Mitic, T., Caporali, A., Lauriola, A., & D’Arca, D.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- The Queen's Medical Research Institute (GB)
- Corresponding author
- D’Arca, Domenico
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2016-01
- Volume
- 2016
- Issue
- 1
- Pages
- 3565127-3565127
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC4877482
- OpenAlex
- W2350256796
- Cited by
- 1,059
- References
- 237
- Citations by year
- 2026: 71 · 2025: 120 · 2024: 143 · 2023: 165 · 2022: 133 · 2021: 137 · 2020: 107 · 2019: 77 · 2018: 63 · 2017: 37 · 2016: 5
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- reactive oxygen species, cellular senescence, aging, age-related diseases, epigenetic regulation, senolytics, healthspan, oxidative stress
- MeSH terms
- Aging, Humans, Cellular Senescence, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.